Research Progress and Application Prospect of Adipose-derived Stem Cell Secretome in Diabetes Foot Ulcers Healing

Overview

Journal Stem Cell Res Ther

Publisher Biomed Central

Date 2024 Sep 3

PMID 39227906

Authors

Xiaofen Wan

Xuejun Ni

Yunjia Xie

Lu Chen

Beichen Cai

Qian Lin

Ruonan Ke

Tao Huang

Xiuying Shan

Biao Wang

Affiliations

Soon will be listed here.

Abstract

Diabetic foot ulcers (DFUs) are chronic wounds and one of the most common complications of diabetes, imposing significant physical and mental burdens on patients due to their poor prognosis and treatment efficacy. Adipose-derived stem cells (ADSCs) have been proven to promote wound healing, with studies increasingly attributing these beneficial effects to their paracrine actions. Consequently, research on ADSC secretome as a novel and promising alternative for DFU treatment has been extensively conducted. This article provides a comprehensive review of the mechanisms underlying refractory DFU wounds, the secretome of ADSCs, and its role in promoting wound healing in diabetes foot ulcers. And the review aims to provide reliable evidence for the clinical application of ADSC secretome in the treatment of refractory DFU wounds.

Citing Articles

The Effect of Adipose-Derived Stem Cell (ADSC)-Exos on the Healing of Autologous Skin Grafts in Miniature Pigs.

Li P, Cao L, Liu T, Lu X, Ma Y, Wang H Int J Mol Sci. 2025; 26(2).

PMID: 39859193 PMC: 11764972. DOI: 10.3390/ijms26020479.

Ultrasmall Antioxidant Copper Nanozyme to Enhance Stem Cell Microenvironment for Promoting Diabetic Wound Healing.

Hou B, Li C, Yang F, Deng W, Hu C, Liu C Int J Nanomedicine. 2024; 19:13563-13578.

PMID: 39720217 PMC: 11668326. DOI: 10.2147/IJN.S487647.

References

Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan B . IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2021; 183:109119. PMC: 11057359. DOI: 10.1016/j.diabres.2021.109119. View

Ji L . Current challenges of diabetes and metabolic disorders in China. Diabetes Obes Metab. 2023; 25 Suppl 1:3-4. DOI: 10.1111/dom.15048. View

McDermott K, Fang M, Boulton A, Selvin E, Hicks C . Etiology, Epidemiology, and Disparities in the Burden of Diabetic Foot Ulcers. Diabetes Care. 2022; 46(1):209-221. PMC: 9797649. DOI: 10.2337/dci22-0043. View

Oyebode O, Jere S, Houreld N . Current Therapeutic Modalities for the Management of Chronic Diabetic Wounds of the Foot. J Diabetes Res. 2023; 2023:1359537. PMC: 9937766. DOI: 10.1155/2023/1359537. View

Chen P, Vilorio N, Dhatariya K, Jeffcoate W, Lobmann R, McIntosh C . Guidelines on interventions to enhance healing of foot ulcers in people with diabetes (IWGDF 2023 update). Diabetes Metab Res Rev. 2023; 40(3):e3644. DOI: 10.1002/dmrr.3644. View

Lazarus H, Haynesworth S, Gerson S, Rosenthal N, Caplan A . Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant. 1995; 16(4):557-64. View

Yuan T, Meijia L, Xinyao C, Xinyue C, Lijun H . Exosome derived from human adipose-derived stem cell improve wound healing quality: A systematic review and meta-analysis of preclinical animal studies. Int Wound J. 2023; 20(6):2424-2439. PMC: 10333007. DOI: 10.1111/iwj.14081. View

Huayllani M, Sarabia-Estrada R, Restrepo D, Boczar D, Sisti A, Nguyen J . Adipose-derived stem cells in wound healing of full-thickness skin defects: a review of the literature. J Plast Surg Hand Surg. 2020; 54(5):263-279. DOI: 10.1080/2000656X.2020.1767116. View

Iacomi D, Rosca A, Tutuianu R, Neagu T, Pruna V, Simionescu M . Generation of an Immortalized Human Adipose-Derived Mesenchymal Stromal Cell Line Suitable for Wound Healing Therapy. Int J Mol Sci. 2022; 23(16). PMC: 9408591. DOI: 10.3390/ijms23168925. View

10.

Ni X, Shan X, Xu L, Yu W, Zhang M, Lei C . Adipose-derived stem cells combined with platelet-rich plasma enhance wound healing in a rat model of full-thickness skin defects. Stem Cell Res Ther. 2021; 12(1):226. PMC: 8022317. DOI: 10.1186/s13287-021-02257-1. View

11.

Zhou Y, Zhao B, Zhang X, Lu Y, Lu S, Cheng J . Combined topical and systemic administration with human adipose-derived mesenchymal stem cells (hADSC) and hADSC-derived exosomes markedly promoted cutaneous wound healing and regeneration. Stem Cell Res Ther. 2021; 12(1):257. PMC: 8088044. DOI: 10.1186/s13287-021-02287-9. View

12.

Singer A . Healing Mechanisms in Cutaneous Wounds: Tipping the Balance. Tissue Eng Part B Rev. 2021; 28(5):1151-1167. PMC: 9587785. DOI: 10.1089/ten.TEB.2021.0114. View

13.

Nowak N, Menichella D, Miller R, Paller A . Cutaneous innervation in impaired diabetic wound healing. Transl Res. 2021; 236:87-108. PMC: 8380642. DOI: 10.1016/j.trsl.2021.05.003. View

14.

Feldman E, Callaghan B, Pop-Busui R, Zochodne D, Wright D, Bennett D . Diabetic neuropathy. Nat Rev Dis Primers. 2019; 5(1):41. DOI: 10.1038/s41572-019-0092-1. View

15.

Armstrong D, Tan T, Boulton A, Bus S . Diabetic Foot Ulcers: A Review. JAMA. 2023; 330(1):62-75. PMC: 10723802. DOI: 10.1001/jama.2023.10578. View

16.

Armstrong D, Boulton A, Bus S . Diabetic Foot Ulcers and Their Recurrence. N Engl J Med. 2017; 376(24):2367-2375. DOI: 10.1056/NEJMra1615439. View

17.

Feldman E, Nave K, Jensen T, Bennett D . New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain. Neuron. 2017; 93(6):1296-1313. PMC: 5400015. DOI: 10.1016/j.neuron.2017.02.005. View

18.

Deng H, Li B, Shen Q, Zhang C, Kuang L, Chen R . Mechanisms of diabetic foot ulceration: A review. J Diabetes. 2023; 15(4):299-312. PMC: 10101842. DOI: 10.1111/1753-0407.13372. View

19.

Nguyen D, Hooshmand Zaferanieh M, Black Jr A, Hamedi K, Goodwin R, Nathaniel T . Obstetric Neuropathy in Diabetic Patients: The "Double Hit Hypothesis". Int J Mol Sci. 2023; 24(7). PMC: 10094911. DOI: 10.3390/ijms24076812. View

20.

Sharma S, Schaper N, Rayman G . Microangiopathy: Is it relevant to wound healing in diabetic foot disease?. Diabetes Metab Res Rev. 2019; 36 Suppl 1:e3244. DOI: 10.1002/dmrr.3244. View